Amalgamated Bank’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.01M | Sell |
14,340
-1,544
| -10% | -$406K | 0.03% | 536 |
|
|
2026
Q1 | $4.24M | Buy |
15,884
+391
| +3% | +$106K | 0.03% | 478 |
|
|
2025
Q4 | $3.89M | Sell |
15,493
-602
| -4% | -$160K | 0.03% | 517 |
|
|
2025
Q3 | $4.62M | Sell |
16,095
-525
| -3% | -$141K | 0.03% | 452 |
|
|
2025
Q2 | $4.36M | Buy |
16,620
+317
| +2% | +$77.2K | 0.03% | 448 |
|
|
2025
Q1 | $3.79M | Buy |
16,303
+248
| +2% | +$60.2K | 0.03% | 484 |
|
|
2024
Q4 | $3.68M | Sell |
16,055
-446
| -3% | -$102K | 0.03% | 533 |
|
|
2024
Q3 | $3.69M | Sell |
16,501
-638
| -4% | -$140K | 0.03% | 533 |
|
|
2024
Q2 | $3.49M | Sell |
17,139
-420
| -2% | -$85.4K | 0.03% | 605 |
|
|
2024
Q1 | $3.84M | Sell |
17,559
-6,184
| -26% | -$1.36M | 0.03% | 590 |
|
|
2023
Q4 | $5.4M | Buy |
23,743
+612
| +3% | +$129K | 0.04% | 432 |
|
|
2023
Q3 | $4.65M | Sell |
23,131
-3,507
| -13% | -$740K | 0.04% | 473 |
|
|
2023
Q2 | $5.52M | Sell |
26,638
-722
| -3% | -$140K | 0.04% | 378 |
|
|
2023
Q1 | $5.39M | Sell |
27,360
-5,435
| -17% | -$1.12M | 0.05% | 385 |
|
|
2022
Q4 | $6.63M | Buy |
32,795
+4,868
| +17% | +$951K | 0.06% | 323 |
|
|
2022
Q3 | $4.91M | Sell |
27,927
-2,101
| -7% | -$430K | 0.05% | 396 |
|
|
2022
Q2 | $6.05M | Buy |
30,028
+2,071
| +7% | +$441K | 0.06% | 319 |
|
|
2022
Q1 | $6.33M | Sell |
27,957
-2,113
| -7% | -$497K | 0.05% | 359 |
|
|
2021
Q4 | $8.12M | Sell |
30,070
-4,076
| -12% | -$1.01M | 0.06% | 300 |
|
|
2021
Q3 | $8.26M | Sell |
34,146
-1,382
| -4% | -$348K | 0.07% | 257 |
|
|
2021
Q2 | $8.42M | Buy |
35,528
+29,310
| +471% | +$6.68M | 0.07% | 275 |
|
|
2021
Q1 | $1.36M | Sell |
6,218
-225
| -3% | -$45.2K | 0.05% | 388 |
|
|
2020
Q4 | $1.13M | Sell |
6,443
-18
| -0.3% | -$3.11K | 0.04% | 463 |
|
|
2020
Q3 | $1.04M | Sell |
6,461
-141
| -2% | -$22.3K | 0.05% | 430 |
|
|
2020
Q2 | $942K | Sell |
6,602
-9,956
| -60% | -$1.38M | 0.04% | 445 |
|
|
2020
Q1 | $1.8M | Sell |
16,558
-634
| -4% | -$91.3K | 0.04% | 398 |
|
|
2019
Q4 | $2.5M | Buy |
17,192
+803
| +5% | +$116K | 0.05% | 390 |
|
|
2019
Q3 | $2.37M | Buy |
16,389
+39
| +0.2% | +$5.69K | 0.05% | 358 |
|
|
2019
Q2 | $2.43M | Buy |
16,350
+1,181
| +8% | +$165K | 0.06% | 318 |
|
|
2019
Q1 | $1.99M | Buy |
15,169
+402
| +3% | +$49.5K | 0.05% | 384 |
|
|
2018
Q4 | $1.6M | Sell |
14,767
-342
| -2% | -$45.8K | 0.05% | 414 |
|
|
2018
Q3 | $2.25M | Sell |
15,109
-362
| -2% | -$55.1K | 0.06% | 324 |
|
|
2018
Q2 | $2.39M | Buy |
15,471
+687
| +5% | +$104K | 0.06% | 310 |
|
|
2018
Q1 | $2.05M | Sell |
14,784
-177
| -1% | -$26K | 0.05% | 357 |
|
|
2017
Q4 | $2.05M | Buy |
14,961
+1,326
| +10% | +$175K | 0.06% | 342 |
|
|
2017
Q3 | $1.77M | Buy |
13,635
+434
| +3% | +$57.9K | 0.06% | 345 |
|
|
2017
Q2 | $1.75M | Buy |
13,201
+4,535
| +52% | +$555K | 0.06% | 334 |
|
|
2017
Q1 | $1.07M | Sell |
8,666
-1,472
| -15% | -$174K | 0.05% | 397 |
|
|
2016
Q4 | $1.12M | Buy |
10,138
+2,271
| +29% | +$252K | 0.05% | 429 |
|
|
2016
Q3 | $929K | Buy |
7,867
+33
| +0.4% | +$3.89K | 0.05% | 410 |
|
|
2016
Q2 | $949K | Buy |
7,834
+3,496
| +81% | +$376K | 0.05% | 393 |
|
|
2016
Q1 | $437K | Buy |
4,338
+1,108
| +34% | +$106K | 0.04% | 609 |
|
|
2015
Q4 | $343K | Sell |
3,230
-959
| -23% | -$98.9K | 0.04% | 674 |
|
|
2015
Q3 | $390K | Buy |
4,189
+131
| +3% | +$13.6K | 0.04% | 684 |
|
|
2015
Q2 | $423K | Buy |
4,058
+177
| +5% | +$18.4K | 0.04% | 693 |
|
|
2015
Q1 | $420K | Buy |
3,881
+1,417
| +58% | +$146K | 0.05% | 496 |
|
|
2014
Q4 | $228K | Sell |
2,464
-387
| -14% | -$34.2K | 0.04% | 737 |
|
|
2014
Q3 | $249K | Buy |
2,851
+84
| +3% | +$7.59K | 0.04% | 683 |
|
|
2014
Q2 | $243K | Buy |
2,767
+170
| +7% | +$14.7K | 0.04% | 721 |
|
|
2014
Q1 | $219K | Sell |
2,597
-52
| -2% | -$4.15K | 0.04% | 710 |
|
|
2013
Q4 | $208K | Buy |
+2,649
| New | +$226K | 0.04% | 750 |
|
Other funds holding LH
CB
RRAM
Amalgamated Bank's LH Position: Q2 2026 in Review
Amalgamated Bank reduced its Labcorp (LH) stake by 9.7% in Q2 2026, selling an estimated $406K and leaving 14,340 shares worth $4.01M. The position accounts for 0.03% of the portfolio, ranked #536.
Amalgamated Bank first reported a position in LH in Q4 2013 and has held it in 51 quarters since. The position peaked at $8.42M in Q2 2021. 563 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Amalgamated Bank held 14,340 shares of Labcorp worth $4.01M as of Q2 2026.
- Amalgamated Bank sold 1,544 Labcorp shares in Q2 2026, an estimated $406K.
- Labcorp made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #536 holding.
- Amalgamated Bank first reported a position in Labcorp in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Labcorp position peaked at $8.42M in Q2 2021.
- 563 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.